Zdrowie i gospodarka · 10/05/2018

FDA Establishes Public Docket for Drug-Drug Interaction Policy Guidance

The FDA is seeking public input to update its framework for assessing drug-drug interactions for therapeutic proteins, following the split of its 2012 draft guidance into two separate documents in 2017.